Summary
Pharma - Healthcare cost - People - Politics - Government - Power.
This is the long link & effect of pharma on global stage !!!
Every Government especially US is crying one chores "Cut Healthcare Cost"
With India having the largest US FDA approved set of manufacturing facilities outside US, India becomes a natural partner.
As the article suggests, outsourcing deals will get bigger & broader.
Pharma will soon see the revolution seen couple of years back in India IT industry!!!
Analysis
Diminishing numbers of new drugs, as against existing drugs going off-patent, high research and development costs, and pressure to reduce healthcare costs are forcing Big Pharma to rope in strategic partners to contain manufacturing and drug development expenses.
India offers a significant cost-quality proposition in end-to-end research and development, with potential savings of over 60 per cent as compared to the US, coupled with a strong supply of skilled manpower and capital efficiency. We could see even more of global pharma companies adopting different operating models such as captive offshoring, dedicated research and development units in partnership, fee for services and collaboration or joint venture for future growth within India.
Global Pharma will never be the same!!!
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
